Classification of Unit-V of Apitoria Pharma Ltd as VAI by the US FDA

The United States Food and Drug Administration (US FDA) inspected Unit-V, an API manufacturing facility, of Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, situated at Industrial Development Area, Chemical Zone, Pashamylaram Village, Patancheru Mandal, Sangareddy District, 502307, Telangana from December 01 to December 12, 2025. At the end of the inspection, a 'Form 483' was issued with 03 observations.

The Unit has now received an Establishment Inspection Report (EIR) classifying the facility as 'Voluntary Action Indicated' (VAI) and this inspection is now "closed".

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1291.40 as compared to the previous close of Rs. 1247.95. The total number of shares traded during the day was 29896 in over 2897 trades.

The stock hit an intraday high of Rs. 1297.00 and intraday low of 1252.35. The net turnover during the day was Rs. 38328389.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 Pharmaceuticals ApitoriaPharma Unit5 VAI USFDA